Specialty Practice
We represent medical, surgical, and aesthetic dermatology practices in confidential transactions with PE-backed dermatology platforms, family offices, and strategic acquirers.
Speak with an advisor: (800) 815-0590Dermatology Track Record
Buyer Network
How We Help
Most dermatology sell-side engagements fall into one of three patterns. Each requires a materially different process, buyer pool, and deal structure.
For high-revenue solo practices receiving direct platform or consolidator inquiries. We run a competitive process to surface multiple offers, defend your terms, and structure the rollover or earn-out that fits your post-close clinical plans.
Discuss your practice →For 2–5+ location groups where you want to monetize equity but remain clinically and operationally involved. We structure rollover percentages, governance, and earn-out terms that protect your economics and your control.
Discuss your group →For groups large enough to be acquired as a platform rather than a tuck-in — typically multi-physician, multi-site, and operationally self-sustaining. We position you with mid-market PE sponsors building or expanding their derm platforms.
Discuss your platform →The Dermatology M&A Market
Dermatology was the second specialty after dental to attract significant PE investment, and a decade of consolidation has produced dozens of active PE-backed platforms operating across nearly every U.S. region. The buyer pool is deep, but materially different in composition from dental.
Cash-pay aesthetic services, Mohs surgery, in-house pathology, and provider-extender models all create distinct value pockets that buyers price differently. Family offices are particularly active for cosmetic-heavy practices, while PE-backed platforms compete intensely for medical and surgical groups with strong recurring patient bases.
Direct platform outreach often surfaces a single offer based on the platform's internal model. A structured process puts your practice in front of multiple sponsors at once, surfacing not just better headline economics but the governance, rollover, and earn-out terms that materially shape your post-close life.
Why It Matters
A direct platform offer is rarely the best offer — and on your own, you have no way of knowing what it isn't. Our process puts your practice in front of the right competing buyers under NDA, surfacing the highest defensible value and the deal structures (rollover, earn-outs, real estate, ancillary income) that actually fit your situation. The cost of running a process is a fraction of the value it surfaces.
Our ProcessValuation Drivers
The headline multiple is the visible number, but it's the product of a dozen underlying inputs. Knowing how buyers weight each one — and where your practice sits on each — is the difference between accepting an offer and negotiating one.
Recent Closings
Placeholder data — replace with real closed dermatology engagements.
View all closed transactions across the 1st Med family of firms →
Know Your Options
Every dermatology practice owner — solo, group, or emerging platform — benefits from a confidential conversation about valuation, deal structure, and timing before engaging with buyers directly. Complete the form or call and speak with a senior advisor today.
(800) 815-0590